Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 367679, 7 pages
http://dx.doi.org/10.1155/2015/367679
Clinical Study

Risk Factors and Prognostic Significance of Retropancreatic Lymph Nodes in Gastric Adenocarcinoma

Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang Street, Chengdu, Sichuan 610041, China

Received 29 October 2014; Accepted 18 December 2014

Academic Editor: Sergio Morini

Copyright © 2015 Lian Xue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. X.-D. Sun, R. Mu, Y.-S. Zhou et al., “Analysis of mortality rate of stomach cancer and its trend in twenty years in China,” Chinese Journal of Oncology, vol. 26, no. 1, pp. 4–9, 2004. View at Google Scholar · View at Scopus
  3. X.-Z. Chen, K. Jiang, J.-K. Hu et al., “Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China,” World Journal of Gastroenterology, vol. 14, no. 17, pp. 2715–2722, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. C.-M. Huang, J.-X. Lin, C.-H. Zheng, P. Li, J.-W. Xie, and B.-J. Lin, “Effect of negative lymph node count on survival for gastric cancer after curative distal gastrectomy,” European Journal of Surgical Oncology, vol. 37, no. 6, pp. 481–487, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. D.-Z. Xu, Q.-R. Geng, Z.-J. Long et al., “Positive lymph node ratio is an independent prognostic factor in gastric cancer after D2 resection regardless of the examined number of lymph nodes,” Annals of Surgical Oncology, vol. 16, no. 2, pp. 319–326, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Marchet, S. Mocellin, A. Ambrosi et al., “The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients,” Annals of Surgery, vol. 245, no. 4, pp. 543–552, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Marubini, F. Bozzetti, R. Miceli, G. Bonfanti, and L. Gennari, “Lymphadenectomy in gastric cancer: prognostic role and therapeutic implications,” European Journal of Surgical Oncology, vol. 28, no. 4, pp. 406–412, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Songun, H. Putter, E. M.-K. Kranenbarg, M. Sasako, and C. J. van de Velde, “Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial,” The Lancet Oncology, vol. 11, no. 5, pp. 439–449, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Cuschieri, P. Fayers, J. Fielding et al., “Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial,” The Lancet, vol. 347, no. 9007, pp. 995–999, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. H. H. Hartgritik, C. J. H. Van De Velde, H. Putter et al., “Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial,” Journal of Clinical Oncology, vol. 22, no. 11, pp. 2069–2077, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Marubini, F. Bozzetti, R. Miceli, G. Bonfanti, and L. Gennari, “Lymphadenectomy in gastric cancer: prognostic role and therapeutic implications,” European Journal of Surgical Oncology, vol. 28, no. 4, pp. 406–412, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. Japanese Gastric Cancer Association, “Japanese gastric cancer treatment guidelines 2010 (ver. 3),” Gastric Cancer, vol. 14, pp. 113–123, 2010. View at Google Scholar
  13. Y. Wan, Y. Pan, Y. Liu, Z. Wang, J. Ye, and S. Huang, “Lymph node metastasis and the extent of lymph node dissection for gastric cancer: report of 326 cases,” Chinese Journal of Gastrointestinal Surgery, vol. 38, no. 10, pp. 752–755, 2000. View at Google Scholar · View at Scopus
  14. D.-F. Shen, D.-W. Chen, Z.-W. Quan et al., “Dissection of No. 13 lymph node in radical gastrectomy for gastric carcinoma,” World Journal of Gastroenterology, vol. 14, no. 6, pp. 936–938, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. B. W. Eom, J. Joo, Y.-W. Kim et al., “Is there any role of additional retropancreatic lymph node dissection on D2 gastrectomy for advanced gastric cancer?” Annals of Surgical Oncology, vol. 20, no. 8, pp. 2669–2675, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. X.-G. Jiao, H. Liang, J.-Y. Deng, L. Wang, H.-G. Liu, and Y.-X. Liang, “The significance of No.13 lymph node dissection in D2 gastrectomy for lower-third advanced gastric cancer,” Chinese Journal of Surgery, vol. 51, no. 3, pp. 235–239, 2013. View at Google Scholar · View at Scopus
  17. G. Peng, Z.-G. Jie, Z.-R. Li et al., “Necessity of no.13 lymph node dissection in advanced gastric carcinoma,” Chinese Journal of Gastrointestinal Surgery, vol. 15, no. 2, pp. 145–148, 2012. View at Google Scholar · View at Scopus
  18. Japanese Gastric Cancer Association, “Japanese classification of gastric carcinoma: 3rd English edition,” Gastric Cancer, vol. 14, pp. 101–112, 2011. View at Publisher · View at Google Scholar
  19. J. A. Ajani, D. J. Bentrem, S. Besh et al., “Gastric cancer (version. 2). 2013: featured updates to the NCCN guidelines,” Journal of the National Comprehensive Cancer Network, vol. 11, pp. 531–546, 2013. View at Google Scholar
  20. Z. C. Wang, P. Dong, and J. Gu, “No.13 lymph node lymphadenectomy in patients of gastric carcinoma,” Chinese Journal of General Surgery, vol. 24, pp. 362–364, 2009. View at Google Scholar
  21. M. Tokunaga, S. Ohyama, N. Hiki et al., “Therapeutic value of lymph node dissection in advanced gastric cancer with macroscopic duodenum invasion: is the posterior pancreatic head lymph node dissection beneficial?” Annals of Surgical Oncology, vol. 16, no. 5, pp. 1241–1246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. E. B. Bostanci, S. Yol, C. Kayaalp et al., “Comparison of complications after D2 and D3 dissection for gastric cancer,” European Journal of Surgical Oncology, vol. 30, no. 1, pp. 20–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Yol, E. B. Bostanci, Y. Ozogul, M. Ulas, and M. Akoglu, “A rare complication of D3 dissection for gastric carcinoma: chyloperitoneum,” Gastric Cancer, vol. 8, no. 1, pp. 35–38, 2005. View at Publisher · View at Google Scholar · View at Scopus